NESS ZIONA, Israel, July 08, 2025 (GLOBE NEWSWIRE) -- BiomX Inc. (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific ...
Premier research journal article provides validation for BiomX’s phage therapy platform, showcasing first-in-human Phase 1b/2a trial results for antibiotic-resistant P. aeruginosa infectionsNew, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results